Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2009-3-9
pubmed:abstractText
A series of cephalosporin-derived reverse hydroxamates and oximes were prepared and evaluated as inhibitors of representative metallo- and serine-beta-lactamases. The reverse hydroxamates showed submicromolar inhibition of the GIM-1 metallo-beta-lactamase. With respect to interactions with the classes A, C, and D serine beta-lactamases, as judged by their correspondingly low K(m) values, the reverse hydroxamates were recognized in a manner similar to the non-hydroxylated N-H amide side chains of the natural substrates of these enzymes. This indicates that, with respect to recognition in the active site of the serine beta-lactamases, the OC-NR-OH functionality can function as a structural isostere of the OC-NR-H group, with the N-O-H group presumably replacing the amide N-H group as a hydrogen bond donor to the appropriate backbone carbonyl oxygen of the protein. The reverse hydroxamates, however, displayed k(cat) values up to three orders of magnitude lower than the natural substrates, thus indicating substantial slowing of the hydrolytic action of these serine beta-lactamases. Although the degree of inactivation is not yet enough to be clinically useful, these initial results are promising. The substitution of the amide N-H bond by N-OH may represent a useful strategy for the inhibition of other serine hydrolases.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19243936-10230626, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243936-11076537, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243936-11158734, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243936-11754593, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243936-12005439, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243936-12051944, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243936-14980686, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243936-15105100, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243936-15125955, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243936-15279575, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243936-15567415, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243936-16022661, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243936-16876996, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243936-16894515, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243936-17266725, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243936-17583502, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243936-18572409, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243936-18942857, http://linkedlifedata.com/resource/pubmed/commentcorrection/19243936-2983675
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1464-3405
pubmed:author
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
19
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1618-22
pubmed:dateRevised
2011-9-26
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Approaches to the simultaneous inactivation of metallo- and serine-beta-lactamases.
pubmed:affiliation
Department of Chemistry, Southern Methodist University, Dallas TX 75275-0314, United States.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural